Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 61-68

  Greene, Michael J ^a   Sam, Flora ^a   Soo Hoo, Pamela T ^a   Patel, Rupesh S ^a   Seldin, David C ^a   Connors, Lawreen H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CHAPERONE; CLUSTERIN; IMMUNOGLOBULIN LIGHT CHAIN; PREALBUMIN;

AMYLOIDOTIC CARDIOMYOPATHY; ARTICLE; BONE MARROW BIOPSY; CARDIOMYOPATHY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VASCULAR AMYLOIDOSIS;

EID: 79251510886     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.015     Document Type: Article

References (22)

1. Lavatelli F, Perlman DH, Spencer B, Prokaeva T, McComb ME, Théberge R, Connors LH, Bellotti V, Seldin DC, Merlini G, Skinner M, Costello CE: Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics 2008, 7:1570-1583
2. Falk RH, Dubrey SW: Amyloid heart disease [Erratum appeared in Prog Cardiovasc Dis 2010, 52:445-447]. Prog Cardiovasc Dis 2010, 52:347-361
3. Shah KB, Inoue Y, Mehra MR: Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006, 166:1805-1813
4. Sawyer DB, Skinner M: Cardiac amyloidosis: shifting our impressions to hopeful. Curr Heart Fail Rep 2006, 3:64-71
5. Hassan W, Al-Sergani H, Mourad W, Tabbaa R: Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Tex Heart Inst J 2005, 32:178-184
6. Bailey RW, Dunker AK, Brown CJ, Garner EC, Griswold MD: Clusterin, a binding protein with a molten globule-like region. Biochemistry 2001, 40:11828-11840
7. Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR: Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 1999, 274:6875-6881 (Pubitemid 129504969)
8. Nuutinen T, Suuronen T, Kauppinen A, Salminen A: Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 2009, 61:89-104
9. Aronow BJ, Lund SD, Brown TL, Harmony JA, Witte DP: Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA 1993, 90:725-729
10. Rosenberg ME, Silkensen J: Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995, 27:633-645
11. Michel D, Chatelain G, North S, Brun G: Stress-induced transcription of the clusterin/apoJ gene. Biochem J 1997, 328:45-50
12. Loison F, Debure L, Nizard P, le Goff P, Michel D, le Dréan Y: Upregulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. Biochem J 2006, 395:223-231
13. Swertfeger D, Witte D, Stuart W, Rockman H, Harmony J: Apolipoprotein J/clusterin induction in myocarditis: a localized response gene to myocardial injury. Am J Pathol 1996, 148:1971-1983
14. Krijnen PAJ, Cillessen SAGM, Manoe R, Muller A, Visser CA, Meijer CJLM, Musters RJP, Hack CE, Aarden LA, Niessen HWM: Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol 2005, 289:H2193-H2202
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458 (Pubitemid 16119719)
16. Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M, Apstein CS, Liao R: Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 2004, 94:1008-1010
17. Shi J, Guan J, Jiang B, Brenner DA, del Monte F, Ward JE, Connors LH, Sawyer DB, Semigran MJ, Macgillivray TE, Seldin DC, Falk R, Liao R: Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway, Proc Natl Acad Sci USA 2010, 107:4188-4193
18. Wilson MR, Easterbrook-Smith SB: Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 2000, 25:95-98
19. Wilson MR, Yerbury JJ, Poon S: Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. Mol BioSyst 2008, 4:42-52
20. Wyatt AR, Wilson MR: Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. J Biol Chem 2010, 285:3532-3539
21. Wyatt AR, Yerbury JJ, Wilson MR: Structural characterization of clusterin-chaperone client protein complexes. J Biol Chem 2009, 284: 21920-21927
22. Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR: The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 2007, 21:2312-2322 (Pubitemid 47230661)